Physician profile
Robert C Hendel
NPI 1790738862
$9,928.76
in general payments reported to CMS, 2019-2025
9 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2021: $68.64 · 2022: $9,174 · 2023: $135 · 2024: $78.48 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $8,940.87 | 2022 | |
| Alnylam Pharmaceuticals INC. | $251.84 | 2022-2025 | Onpattro |
| Ge Healthcare | $199.32 | 2019-2025 | |
| Pfizer INC. | $196.98 | 2022-2024 | |
| Biotronik INC. | $134.69 | 2023 | Orsiro Mission, Pk Papyrus |
| Medtronic Vascular, INC. | $121.68 | 2019 | |
| Jubilant Draximage INC. | $68.64 | 2021 | |
| Siemens Medical Solutions USA, INC. | $14.74 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hendel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.